The genus Oxytropis DC: application, phytochemistry, pharmacology, and toxicity
Journal of Pharmacy and Pharmacology · 2024
DOI: 10.1093/jpp/rgae048 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Bingkang Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, PR China. Hauptthemen laut MEDLINE: Oxytropis, Plant Extracts. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 188 Literaturangaben. Gefördert von: Shandong Province Key Research and Development Program.
Abstract (Originalsprache)
Objectives Oxytropis DC is a perennial plant of Fabaceae family, which is widely distributed in the northern temperate zone. It is known as “locoweed” because of its toxic component swainsonine. However, it is widely used in Tibetan medicine and Mongolian medicine, mainly for the treatment of heat-clearing and detoxifying, pain-relieving, anti-inflammatory, hemostasis, and other diseases. To provide a basis for the further development and utilization of Oxytropis DC, the pieces of literature about the application, phytochemistry, pharmacological action, and toxicity of Oxytropis DC were reviewed and analyzed. Key findings A total of 373 chemical constituents were found from Oxytropis DC, including flavonoids, alkaloids, steroids, terpenoids, and others. Pharmacological actions mainly include antitumor, antioxidation, anti-inflammatory, analgesic, antibacterial, antifibrosis, and other pharmacological actions, among them, the antitumor effect is particularly prominent. Summary At present, studies on its pharmacological effects are mainly concentrated on the extracts, some flavonoids, and alkaloids. In the follow-up studies, research on the pharmacological activities of the other chemical constituents in Oxytropis should be strengthened. It has the potential to pave the way for research and development of novel Oxytropis medicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, PR China.
- Great Health Products Research Institute, Shandong Academy of Chinese Medicine, Jinan 250014, PR China.
- Shandong Modern Research and Development Engineering Center of Traditional Chinese Medicine Aromatherap, Jinan 250014, PR China.
- Key Laboratory of Traditional Chinese Medicine Classical Theory, Ministry of Education, Shandong University of Traditional Chinese Medicine, Jinan 250355, PR China.
ORCID-Profile: Honglei Zhou
Förderung
- Shandong Province Key Research and Development Program
Zitieren
APA
Wang, B., Tian, Z., Lang, S., Kong, Q., Liu, X., Chen, Y., Hua, M., Zhou, Q., Yu, X., Feng, H., Wang, F., & Zhou, H. (2024). The genus Oxytropis DC: application, phytochemistry, pharmacology, and toxicity. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae048
Vancouver
Wang B, Tian Z, Lang S, Kong Q, Liu X, Chen Y, et al. The genus Oxytropis DC: application, phytochemistry, pharmacology, and toxicity. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgae048
BibTeX
@article{Wang2024,
author = {Wang, Bingkang and Tian, Zhenhua and Lang, Shiyue and Kong, Qinghe and Liu, Xue and Chen, Yueru and Hua, Min and Zhou, Qian and Yu, Xiaofei and Feng, Hao and Wang, Fulin and Zhou, Honglei},
title = {The genus Oxytropis DC: application, phytochemistry, pharmacology, and toxicity},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
doi = {10.1093/jpp/rgae048}
}
EUVIMED